Review article: Efficacy and safety of rabeprazole in treating gastroesophageal reflux disease

被引：1

作者：

Lim, PWY

Goh, KL

机构：

[1] Eisai Asia Reg Serv Pte Ltd, Singapore 189721, Singapore

[2] Univ Malaya, Kuala Lumpur, Malaysia

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2004年 / 19卷

关键词：

gastroesophageal reflux disease; second generation PPI; CYP4502C19 genetic polymorphism; on-demand;

D O I：

10.1111/j.1440-1746.2004.03592.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Proton pump inhibitors (PPI) are the mainstay of gastroesophageal reflux disease (GERD) treatment. They have a good efficacy and short- and long-term safety profile. Rabeprazole is a second generation PPI with rapid onset of action that quickly relieves symptoms of GERD. Rabeprazole consistently and profoundly inhibits gastric acid secretion. Its metabolism is less dependent on CYP4502C19 system and therefore is the least affected among all PPIs by CYP4502C19 genetic polymorphism. Recent studies have also indicated that rabeprazole on-demand is cost effective in preventing non-erosive reflux disease (NERD) symptom relapse.

引用

页码：S61 / S68

页数：8

共 50 条

[11] Efficacy and safety of esomeprazole with flupentixol/melitracen in treating gastroesophageal reflux disease patients with emotional disorders
Yu, Yan-Yan
Fang, Dian-Chun
Fan, Li-Lin
Chang, Hui
Wu, Zhi-Lin
Cao, Yan
Lan, Chun-Hui
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (06) : 1200 - 1206
[12] EFFICACY OF ANTACIDS IN TREATING GASTROESOPHAGEAL REFLUX (GERD) IN INFANTS: A LITERATURE REVIEW
Tran, C. N.
Huang, C. J.
Sun, R. M.
Hall, M. C.
Somani, A.
Alety, N.
Chheang, M.
Afghani, B.
JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (01) : 205 - 206
[13] Revaluation of the efficacy of magnetic sphincter augmentation for treating gastroesophageal reflux disease
Hongke Zhang
Dinghui Dong
Zhengwen Liu
Shuixiang He
Liangshuo Hu
Yi Lv
Surgical Endoscopy, 2016, 30 : 3684 - 3690
[14] Revaluation of the efficacy of magnetic sphincter augmentation for treating gastroesophageal reflux disease
Zhang, Hongke
Dong, Dinghui
Liu, Zhengwen
He, Shuixiang
Hu, Liangshuo
Lv, Yi
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (09): : 3684 - 3690
[15] Sleep Dysfunction in Japanese Patients with Gastroesophageal Reflux Disease: Prevalence, Risk Factors, and Efficacy of Rabeprazole
Fujiwara, Yasuhiro
Kohata, Yukie
Kaji, Makiko
Nebiki, Hiroko
Yamasaki, Tomoaki
Sasaki, Eiji
Hayakawa, Tsuyoshi
Machida, Hirohisa
Tanigawa, Tetsuya
Watanabe, Kenji
Watanabe, Toshio
Tominaga, Kazunari
Arakawa, Tetsuo
DIGESTION, 2010, 81 (03) : 135 - 141
[16] Gastroesophageal reflux disease in diabetes: Characteristics and treatment with rabeprazole.
Hasegawa, N
Watanabe, T
Tanaka, H
Matsui, J
Ogawa, Y
Nakamura, T
Kikuchi, H
Takeuchi, T
GASTROENTEROLOGY, 2000, 118 (04) : A1244 - A1244
[17] GASTROESOPHAGEAL REFLUX IN PREGNANCY - REVIEW ARTICLE
HEY, VMF
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1978, 6 : 18 - 25
[18] Safety and Efficacy of Wireless pH Monitoring in Patients Suspected of Gastroesophageal Reflux Disease A Systematic Review
Kessels, Sharon J. M.
Newton, Skye S.
Morona, Judy K.
Merlin, Tracy L.
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2017, 51 (09) : 777 - 788
[19] Efficacy of rabeprazole for the treatment of gastroesophageal reflux disease in a 7-day non-interventional trial
Tsukanov, Vladislav V.
Onuchina, Elena V.
Vasyutin, Alexander V.
Dambaeva, Bairma B.
Tonkikh, Julia L.
Pavlova, Nadezhda V.
TERAPEVTICHESKII ARKHIV, 2024, 96 (08) : 804 - 811
[20] Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
Hou, Mingying
Hu, Haiqing
Jin, Chunlu
Yu, Xuemei
IRANIAN JOURNAL OF PUBLIC HEALTH, 2020, 49 (12) : 2264 - 2274

← 1 2 3 4 5 →